SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000930413-18-000950
Filing Date
2018-03-12
Accepted
2018-03-12 17:01:10
Documents
64
Period of Report
2018-01-31

Document Format Files

Seq Description Document Type Size
1 c90685_10q.htm 10-Q 655533
2 c90685_ex31-1.htm EX-31.1 8975
3 c90685_ex31-2.htm EX-31.2 8967
4 c90685_ex32-1.htm EX-32.1 3098
5 c90685_ex32-2.htm EX-32.2 3043
  Complete submission text file 0000930413-18-000950.txt   4093428

Data Files

Seq Description Document Type Size
6 enz-20180131.xml EX-101.INS 953761
7 enz-20180131.xsd EX-101.SCH 48153
8 enz-20180131_cal.xml EX-101.CAL 40897
9 enz-20180131_def.xml EX-101.DEF 204040
10 enz-20180131_lab.xml EX-101.LAB 313565
11 enz-20180131_pre.xml EX-101.PRE 211878
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 001-09974 | Film No.: 18684198
SIC: 8071 Services-Medical Laboratories
Assistant Director 9